Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population.
Saved in:
| Title: | Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. |
|---|---|
| Authors: | Thompson, Elizabeth J.1,2,3 (AUTHOR), Jeong, Angela1 (AUTHOR), Helfer, Victória E.1 (AUTHOR), Shakhnovich, Valentina4,5,6 (AUTHOR), Edginton, Andrea7 (AUTHOR), Balevic, Stephen J.2,3 (AUTHOR), James, Laura P.8 (AUTHOR), Collier, David N.9 (AUTHOR), Anand, Ravinder10 (AUTHOR), Gonzalez, Daniel3,11 (AUTHOR) daniel.gonzalez@duke.edu, Benjamin, Daniel K. (AUTHOR), Kennel, Phyllis (AUTHOR), Alderman, Cheryl (AUTHOR), Sund, Zoe (AUTHOR), Opel, Kylie (AUTHOR), Beci, Rose (AUTHOR), Hornik, Chi D. (AUTHOR), Kearns, Gregory L. (AUTHOR), Paul, Ian M. (AUTHOR), Sullivan, Janice (AUTHOR) |
| Source: | CPT: Pharmacometrics & Systems Pharmacology. Aug2024, Vol. 13 Issue 8, p1394-1408. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21638306 |
|---|---|
| DOI: | 10.1002/psp4.13167 |
